NextFin News - Private-equity sponsors, blocked from selling portfolio companies through IPOs and trade sales, are manufacturing their own exits. GP-led continuation vehicles surpassed LP-led sales in the first half of 2026, accounting for $65 billion of a record $121 billion in secondary-market volume, as managers use the structure to return cash to investors and book realizations that lift reported fund returns.
The Exit Door That Wasn't There
For most of the past three years, private-equity firms have faced a simple, uncomfortable problem: they could not sell. The IPO window that swung wide in 2020 and 2021 shut as interest rates rose, and strategic buyers grew cautious. Without exits there were no distributions, and without distributions limited partners grew restless.
The secondaries market absorbed the pressure. Full-year 2025 volume reached a record $226 billion, up 41% year over year, according to Evercore's Private Capital Advisory group; LP-led sales rose 34% to $120 billion while GP-led transactions jumped roughly 50% to $106 billion. A separate industry review from Jefferies put 2025 volume higher, at $240 billion, up 48%, but both providers agree on the direction and the driver: liquidity demand is outrunning the traditional exit market.
The acceleration continued into 2026. Volume in the first six months hit $121 billion, a 19% increase over the same period a year ago and a record first half, with GP-led deals rising 35% to $65 billion and LP-led transactions at $56 billion. For the full year, the market is on track for $250 billion, Nigel Dawn, global head of Evercore's private capital advisory group, said in an interview. That would leave 2026 volume more than double the $106 billion in GP-led deals recorded for all of 2025 if the second half holds pace.
The composition is what turns a liquidity market into an exit market. When LPs sell fund stakes to other investors, assets simply change owners. When a sponsor moves a company into a continuation vehicle, the old fund records a realization, books a gain, and distributes cash. The internal rate of return jumps even though the underlying business has not been tested by an independent buyer. That accounting effect is precisely why the structure has become the lifeline of choice.
The Pressure Behind the Trade
The demand for exits is not discretionary. It is mechanical. Private-equity funds have fixed lives, usually ten years with extensions, and at some point they must return capital. The capital they need to return has been growing faster than the exit market's ability to absorb it. Funds raised during the cheap-money years of 2020 and 2021 are now in their distribution phase, and the assets they hold were underwritten at valuations that assumed lower discount rates and higher exit multiples.
That mismatch shows up in what allocators call the denominator effect. When public-market valuations fall, the private assets in a pension fund or endowment portfolio do not reprice immediately. The public side shrinks while the private side stays marked at older, higher values, pushing the private allocation above its target. The fix is to sell private exposure, which is why LP-led volume rose 34% in 2025 even before the GP-led wave took over. The secondaries market became the pressure valve for balance sheets that had drifted out of alignment.
For the GP, the pressure is different but equally binding. A fund that cannot distribute capital cannot raise the next one. Institutional investors judge a manager on realized returns, not paper marks, and the gap between the two has widened across the industry. A continuation vehicle closes that gap by design: it converts an unrealized mark into a realized number, and a realized number is what appears in the pitch book for the next fund.
How the Lifeline Actually Works
A continuation vehicle is a controlled handoff. The general partner moves one or more assets from an aging fund into a new vehicle it also manages. Existing limited partners get a choice: take cash now, or roll their stake into the new structure and stay invested. The GP keeps managing the asset, collects fees on both sides of the transaction, and buys time to wait for a better exit window.
That time is the product being sold. For the LP, the alternative is often nothing at all. A stake in a fund whose assets cannot be sold produces no cash flow, no rebalancing option, and a widening gap between the reported net asset value and the price anyone would actually pay. The continuation vehicle converts an illiquid paper position into a priced transaction, even when the price is set by the sponsor itself.
The mechanism has spread beyond private equity into publicly traded vehicles. BlackRock's TCP Capital Corp said it is selling a $523 million portfolio of private-credit investments, transferring 95% of the equity interests in a continuation vehicle holding approximately $523 million of investments across 78 portfolio companies, about 48% of its debt portfolio by fair value before the deal. The transaction cuts leverage from 1.38x to an expected 0.4x. It is a balance-sheet reset dressed as a portfolio repositioning, and it shows how the structure has migrated from a niche tool into a mainstream liquidity instrument.
Managers are also learning which assets belong in a continuation vehicle and which belong in an IPO. Blackstone took Jersey Mike's Subs public this year at a valuation of around $8 billion, with up to $1.09 billion of shares for sale in one of the largest U.S. restaurant offerings in years, after buying a majority stake early last year for about $6 billion plus debt. When the public window opens, sponsors will still run through it. The secondaries market is the backstop for everything else.
Why Returns Look Better on Paper
The accounting logic makes the lifeline hard to resist. A private-equity fund's internal rate of return is driven heavily by the timing of cash flows: the sooner capital comes back, the higher the IRR. A continuation vehicle produces a realization event without requiring an arms-length sale. For a sponsor raising a new fund, the track record of the prior vintage is the sales pitch. A fund that shows realizations and distributions looks healthy. A fund that shows nothing but unrealized gains looks stuck. The difference shows up in the next fundraising deck and in the management fees that fund the firm itself.
There is a second, subtler effect. Because the GP sets the transaction price, the realization can be timed to coincide with fundraising. A well-timed continuation deal can lift a vintage's multiple just as the manager is asking investors for new commitments. The incentive is not hidden; it is built into the fee structure. The GP earns management fees on the assets while they sit in the old fund, fees again when they move into the new vehicle, and carried interest if the assets appreciate further.
Large managers that can offer liquidity options are winning capital from those that cannot. Ares Management reported record quarterly fundraising of approximately $36 billion for the three months ended June 30, with net inflows of $34.4 billion and deployment of $35.9 billion, up from $27 billion a year earlier. Its assets under management climbed 17% to $671 billion. In a market where investors are rationing commitments, the ability to return capital is becoming a competitive advantage in raising it.
The structure also lets sponsors keep their best assets. GPs are using continuation vehicles to retain what Dawn calls "trophy" assets, the kind of high-performing companies that managers believe still have significant upside left. That is the flip side of the liquidity story: the assets most likely to produce the next generation of returns are the ones least likely to leave the sponsor's control.
Fund managers are using continuation vehicles to retain what Dawn calls "trophy" assets, the kind of high-performing companies that GPs believe still have significant upside left.
The Counter-Thesis: It Is Not a Real Exit
Critics argue that a continuation vehicle is not an exit at all. The asset has not been tested by the market. The price has not been discovered through competitive bidding. The risk has not left the ecosystem; it has been repackaged. In the harshest reading, the boom in GP-led deals is "extend and pretend," a way to delay recognizing losses on assets that would not clear in an open auction.
There is evidence on that side. LP-led sales still accounted for the majority of 2025 volume at $120 billion, and even in the first half of 2026 they represented $56 billion of activity, meaning distressed sellers rebalancing portfolios remain a substantial force. The conflicts are also real: the GP sits on both sides of the transaction, setting the price and collecting fees on both the selling and the buying vehicle. Independent fairness opinions and limited-partner advisory committees are meant to police this, but they are paid by the very structure they review.
The strongest version of the counter-thesis does not claim the whole market is corrupt. It claims the margin between the continuation-vehicle price and the true market-clearing price is widening, and that the difference is being booked as performance. If that margin is large, today's distributions are tomorrow's write-downs in disguise. The test of that claim is empirical, not rhetorical: it requires tracking what happens to continuation-vehicle assets when they finally reach an IPO or a trade sale.
Cyclical or Structural?
This is the call that determines how to read the next three years. Is the secondaries lifeline a cyclical bridge that disappears when the IPO market reopens, or a structural change in how private capital exits?
The cyclical leg is clear. Higher rates killed the IPO and leveraged-buyout exit market, and any rate-cutting cycle would loosen it again. The Jersey Mike's offering shows that when the window opens, sponsors will use it. A recovery in trade sales would pull volume back toward LP-led transactions and reduce the need for sponsor-controlled exits. History offers a template: after the global financial crisis, the secondaries market expanded as a liquidity tool and then receded as IPOs recovered, leaving the segment smaller and more specialized than it is today.
But the structural leg is stronger, for three reasons that do not reverse on their own. First, the stock of unsold private assets is at a record, built up over years of heavy investing; even a healthy IPO market cannot clear it quickly. Second, the secondaries market has industrialized: more than 150 sponsors now execute repeat continuation-vehicle transactions, and the market has developed its own buyers, pricing conventions, and distribution channels. A market that size develops institutional memory and repeat players; it does not shrink back to a niche when conditions normalize. Third, LPs have learned that they can demand liquidity without waiting for permission. Once that expectation exists, it does not go away.
One constraint tempers the structural call. Estimated dry powder in the secondaries space stands at $194 billion, down 10% year-to-date, which means buyers have roughly enough firepower to cover another half-year of activity at the current pace. If deal volume keeps growing while dry powder keeps shrinking, pricing discipline will be tested, and the gap that critics worry about will widen. The lifeline depends on buyers with capital, and that capital is being drawn down faster than it is being replaced.
The second-order effect is what most investors are missing. The lifeline changes the bargaining power between general and limited partners. An LP who knows a continuation vehicle exists can pressure the GP for a liquidity option. A GP who refuses risks losing the next fund. The price of private-market capital has risen, and it is being paid in flexibility rather than in illiquidity premium. That shift redistributes value inside the asset class: from sponsors who prefer evergreen control to LPs who now hold a credible exit threat.
What to Watch
Three signals will tell whether this is a bridge or a new road. First, the share of GP-led volume in total secondaries: if it falls back below 40% as IPO activity recovers, the lifeline was cyclical. Second, the spread between continuation-vehicle valuations and subsequent IPO or trade-sale prices for the same assets; a widening gap confirms the "paper gains" critique. Third, distribution yields to LPs across the industry; if they return to 2021 highs while exit markets stay closed, the mechanism is working as advertised.
The base case is that secondaries remain the dominant exit channel through 2027, with GP-led deals holding near half of volume and full-year totals approaching the $250 billion trajectory. The upside case for sponsors is an IPO rebound that lets them price assets in the open market while keeping the secondaries option as a backstop. The downside case is a recession that forces true price discovery, turning continuation vehicles from liquidity tools into loss-delay vehicles.
Private equity spent decades selling the promise that illiquidity earns a premium. The secondaries boom is the market's answer: illiquidity earns a premium only until investors figure out how to trade it. The lifeline is real. The question is who it is saving.
Explore more exclusive insights at nextfin.ai.
